THY1 and hepatocellular carcinoma: CD90 is a hepatocellular carcinoma CSC marker [126] and delivery of exosomal miR-125a and miR-125b have been reported to suppress CD90 expression in hepatocellular carcinoma cells to decrease their stemness [99].